Vertex Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $12.67; its P/E ratio is 25.40; Vertex Pharmaceuticals is scheduled to report earnings on February 7, 2023, and the estimated EPS forecast is $3.53. See an overview of income statement, balance sheet, and cash flow financials.

	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21
Income Statement	-
Total Revenue	$ 2.33B	$ 2.20B	$ 2.10B	$ 2.07B	$ 1.98B
Gross Profit	$ 2.04B	$ 1.93B	$ 1.85B	$ 1.83B	$ 1.75B
EBIT	$ 1.19B	$ 1.04B	$ 969.70M	$ 886.04M	$ 1.10B
EBITDA	$ 1.23B	$ 1.08B	$ 1.01B	$ 919.88M	$ 1.13B
Net Income Common Stockholders	$ 930.50M	$ 810.50M	$ 762.10M	$ 770.11M	$ 851.93M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 9.77B	$ 9.25B	$ 8.24B	$ 7.52B	$ 6.96B
Total Assets	$ 16.71B	$ 15.58B	$ 14.26B	$ 13.43B	$ 12.62B
Total Debt	$ 824.60M	$ 847.30M	$ 872.50M	$ 934.10M	$ 876.80M
Net Debt	$ -8.95B	$ -8.41B	$ -7.37B	$ -6.59B	$ -6.08B
Total Liabilities	$ 3.68B	$ 3.65B	$ 3.35B	$ 3.33B	$ 3.09B
Stockholders Equity	$ 13.03B	$ 11.93B	$ 10.91B	$ 10.10B	$ 9.53B
Cash Flow	-
Free Cash Flow	$ 901.30M	$ 1.09B	$ 892.60M	$ 933.28M	$ 874.70M
Operating Cash Flow	$ 955.50M	$ 1.14B	$ 956.20M	$ 994.99M	$ 927.22M
Investing Cash Flow	$ -384.20M	$ -61.50M	$ -51.00M	$ -134.00M	$ -52.95M
Financing Cash Flow	$ -60.20M	$ 47.70M	$ -95.40M	$ -336.24M	$ -656.66M

Currency in USD

Vertex Pharmaceuticals Earnings and Revenue History

Income Statement >

Vertex Pharmaceuticals Debt to Assets

Balance Sheet >

Vertex Pharmaceuticals Cash Flow

Cash Flow >

Vertex Pharmaceuticals Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing